| Jessa Irene Dauria, ARNP | |
|
217 N Aurora St, Ithaca, NY 14850-4345 | |
| (607) 273-2811 | |
| Not Available |
| Full Name | Jessa Irene Dauria |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 217 N Aurora St, Ithaca, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013244722 | NPI | - | NPPES |
| 9664202 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | AP60116854 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessa Irene Dauria, ARNP 218 S Albany St, Apt 2, Ithaca, NY 14850-5404 Ph: (206) 724-2305 | Jessa Irene Dauria, ARNP 217 N Aurora St, Ithaca, NY 14850-4345 Ph: (607) 273-2811 |
News Archive
A new study using brevetoxin-2, a compound produced naturally by marine algae, stimulated nerve cell growth and plasticity in cultured mouse neurons. This research advances a potentially new pharmacological treatment to aid recovery of brain function following a stroke or other traumatic brain injury.
TeleTracking Technologies (www.teletracking.com), the KLAS category leader in patient flow technology, will highlight future trends in patient flow, including the paradigm-shifting potential of sensor networks, during the 2010 HIMSS conference March 1 in Atlanta, GA.
Breast cancer patients could get more reliable idea of how long they will live now scientists have linked a new group of genes to poor prognosis.
Studies have shown that family history is a risk factor for COPD, but have not accounted for family history of smoking. Researchers from Brigham and Women's Hospital, the University of Colorado, and National Jewish Health compared 821 COPD cases with 776 control smokers from the COPD Gene Study, capturing parental smoking and COPD histories, along with environmental tobacco smoke exposure.
Eisai Inc. announced today results from the Phase III SELECT trial of investigational agent lenvatinib evaluating progression-free survival (PFS) in patients with progressive radioiodine-refractory differentiated thyroid cancer (RR-DTC).
› Verified 3 days ago
Judith Scherer, NP FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 209 W State St, Ithaca, NY 14850 Phone: 607-257-5263 Fax: 607-216-0902 | |
Deborah D Mcintyre, RN NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 821 Cliff St, Ithaca, NY 14850 Phone: 607-273-7700 Fax: 607-273-6958 | |
Ms. Eleanor Kraft Sanders, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 204 N Cayuga St, Ithaca, NY 14850 Phone: 607-273-7494 Fax: 607-273-7484 | |
Mrs. Jolene S Burun, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2432 N Triphammer Rd, Ithaca, NY 14850 Phone: 607-272-0460 | |
Bonnie Lefkowitz-white, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 217 N Aurora St, Ithaca, NY 14850 Phone: 607-273-2811 Fax: 607-273-1170 | |
Mr. Benjamin J Kornblum, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 302 W Seneca St, Ithaca, NY 14850 Phone: 607-697-0360 |